Amylyx receives EU Orphan Drug Designation for Wolfram syndrome treatment

KVK Tech registers Lomaira 8mg tablets in Mexico

GSK's Arexvy receives positive CHMP opinion for at-risk adults aged 50-59

M8 Pharmaceuticals signs exclusive licensing and distribution agreement with LG Chem

FDA feedback boosts Diamyd Medical's pathway to accelerated approval for Type 1 Diabetes Therapy

StimAire names new chief operating officer

TME Pharma to monetise clinical asset NOX-E36 for ophthalmology

Innovent Biologics announces data from second phase three clinical trial of mazdutide in Chinese patients with Type 2 Diabetes

Diamyd Medical's Diamyd (rhGAD65/alum) receives Fast Track designation for type 1 diabetes treatment in paediatric patients

Genentech reports positive Phase I Results for oral GLP-1 agonist CT-996

Eluminex Biosciences doses first patient in EB 105 phase 1b Lotus trial in Diabetic Macular Edema

Novo Nordisk receives FDA response letter for once-weekly basal insulin icodec

Genentech gains FDA approval for Vabysmo prefilled syringe in treating causes of vision loss

AbbVie names new CEO

Gan & Lee Pharmaceuticals announces results of Phase 1b/2a clinical study of and results of two other innovative insulins' preclinical studies